A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA)
Sanofi
Sanofi
Fondazione IRCCS Policlinico San Matteo di Pavia
Eastern Cooperative Oncology Group
Boston Medical Center
Barbara Ann Karmanos Cancer Institute
Oncopeptides AB
M.D. Anderson Cancer Center
Tufts Medical Center
GlaxoSmithKline
Prothena Biosciences Ltd.
Prothena Biosciences Ltd.
Boston Medical Center
Fondazione IRCCS Policlinico San Matteo di Pavia
Boston Medical Center
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
European Organisation for Research and Treatment of Cancer - EORTC
Rutgers, The State University of New Jersey